Literature DB >> 25639893

Applications of mass spectrometry in drug metabolism: 50 years of progress.

Bo Wen1, Mingshe Zhu.   

Abstract

Mass spectrometry plays a pivotal role in drug metabolism studies, which are an integral part of drug discovery and development nowadays. Metabolite identification has become critical to understanding the metabolic fate of drug candidates and to aid lead optimization with improved metabolic stability, toxicology and efficacy profiles. Ever since the introduction of atmospheric ionization techniques in the early 1990s, liquid chromatography coupled with mass spectrometry (LC/MS) has secured a central role as the predominant analytical platform for metabolite identification as LC and MS technologies continually advanced. In this review, we discuss the evolution of both MS technology and its applications over the past 50 years to meet the increasing demand of drug metabolism studies. These advances include ionization sources, mass analyzers, a wide range of MS acquisition strategies and data mining tools that have substantially accelerated the metabolite identification process and changed the overall drug metabolism landscape. Exemplary applications for characterization and identification of both small-molecule xenobiotics and biological macromolecules are described. In addition, this review discusses novel MS technologies and applications, including xenobiotic metabolomics that hold additional promise for advancing drug metabolism research, and offers thoughts on remaining challenges in studying the metabolism and disposition of drugs and other xenobiotics.

Entities:  

Keywords:  LC/MS; Mass spectrometry; biotransformation; drug metabolism; high-resolution MS; metabolite identification

Mesh:

Substances:

Year:  2015        PMID: 25639893     DOI: 10.3109/03602532.2014.1001029

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  10 in total

1.  Characterization of the Impact of Drug Metabolism on the Gas-Phase Structures of Drugs Using Ion Mobility-Mass Spectrometry.

Authors:  Dylan H Ross; Ryan P Seguin; Libin Xu
Journal:  Anal Chem       Date:  2019-10-29       Impact factor: 6.986

2.  Pharmacokinetics, distribution, and excretion of sodium oligomannate, a recently approved anti-Alzheimer's disease drug in China.

Authors:  Jiaojiao Lu; Qiongqun Pan; Jieqiang Zhou; Yan Weng; Kaili Chen; Lv Shi; Guanxiu Zhu; Chunlin Chen; Liang Li; Meiyu Geng; Zhenqing Zhang
Journal:  J Pharm Anal       Date:  2021-06-05

3.  High-Throughput Measurement and Machine Learning-Based Prediction of Collision Cross Sections for Drugs and Drug Metabolites.

Authors:  Dylan H Ross; Ryan P Seguin; Allison M Krinsky; Libin Xu
Journal:  J Am Soc Mass Spectrom       Date:  2022-05-11       Impact factor: 3.262

4.  Mass Spectrometry Applications for Toxicology.

Authors:  Michael M Mbughuni; Paul J Jannetto; Loralie J Langman
Journal:  EJIFCC       Date:  2016-12-01

5.  Structure elucidation of metabolite x17299 by interpretation of mass spectrometric data.

Authors:  Qibo Zhang; Lisa A Ford; Anne M Evans; Douglas R Toal
Journal:  Metabolomics       Date:  2017-06-24       Impact factor: 4.290

6.  Characterization of the in Vitro Metabolic Profile of Evodiamine in Human Liver Microsomes and Hepatocytes by UHPLC-Q Exactive Mass Spectrometer.

Authors:  Zhaowei Zhang; Tianzi Fang; Hongyun Zhou; Jie Yuan; Qingwang Liu
Journal:  Front Pharmacol       Date:  2018-02-22       Impact factor: 5.810

7.  New Perspectives on Acyl Glucuronide Risk Assessment in Drug Discovery: Investigation of In vitro Stability, In situ Reactivity, and Bioactivation.

Authors:  Mithat Gunduz; Upendra A Argikar; Amanda L Cirello; Jennifer L Dumouchel
Journal:  Drug Metab Lett       Date:  2018

Review 8.  Mass spectrometry-based chemical mapping and profiling toward molecular understanding of diseases in precision medicine.

Authors:  Yechen Hu; Zhongcheng Wang; Liang Liu; Jianhua Zhu; Dongxue Zhang; Mengying Xu; Yuanyuan Zhang; Feifei Xu; Yun Chen
Journal:  Chem Sci       Date:  2021-05-25       Impact factor: 9.825

9.  Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes.

Authors:  Xingxing Diao; Karl B Scheidweiler; Ariane Wohlfarth; Mingshe Zhu; Shaokun Pang; Marilyn A Huestis
Journal:  Forensic Toxicol       Date:  2016-03-28       Impact factor: 4.096

10.  Using LC Retention Times in Organic Structure Determination: Drug Metabolite Identification.

Authors:  William L Fitch; Cyrus Khojasteh; Ignacio Aliagas; Kevin Johnson
Journal:  Drug Metab Lett       Date:  2018
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.